109 related articles for article (PubMed ID: 18491049)
1. Scaffold/matrix attachment regions (S/MARs): relevance for disease and therapy.
Gluch A; Vidakovic M; Bode J
Handb Exp Pharmacol; 2008; (186):67-103. PubMed ID: 18491049
[TBL] [Abstract][Full Text] [Related]
2. Role of chromatin/epigenetic modifications on DNA accessibility.
Georgel PT
Drug News Perspect; 2007 Nov; 20(9):549-56. PubMed ID: 18176659
[TBL] [Abstract][Full Text] [Related]
3. Epigenome-derived drugs: recent advances and future perspectives.
Vogiatzi P; Aimola P; Scarano MI; Claudio PP
Drug News Perspect; 2007 Dec; 20(10):627-33. PubMed ID: 18301797
[TBL] [Abstract][Full Text] [Related]
4. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead.
Mai A; Altucci L
Int J Biochem Cell Biol; 2009 Jan; 41(1):199-213. PubMed ID: 18790076
[TBL] [Abstract][Full Text] [Related]
5. Correlations between scaffold/matrix attachment region (S/MAR) binding activity and DNA duplex destabilization energy.
Bode J; Winkelmann S; Götze S; Spiker S; Tsutsui K; Bi C; A K P; Benham C
J Mol Biol; 2006 Apr; 358(2):597-613. PubMed ID: 16516920
[TBL] [Abstract][Full Text] [Related]
6. Novel approaches on epigenetics.
Papait R; Monti E; Bonapace IM
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):264-75. PubMed ID: 19333872
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic deregulation of DNA repair and its potential for therapy.
Hegi ME; Sciuscio D; Murat A; Levivier M; Stupp R
Clin Cancer Res; 2009 Aug; 15(16):5026-31. PubMed ID: 19671858
[TBL] [Abstract][Full Text] [Related]
8. MARs and MARBPs: key modulators of gene regulation and disease manifestation.
Chattopadhyay S; Pavithra L
Subcell Biochem; 2007; 41():213-30. PubMed ID: 17484130
[TBL] [Abstract][Full Text] [Related]
9. A map of nuclear matrix attachment regions within the breast cancer loss-of-heterozygosity region on human chromosome 16q22.1.
Shaposhnikov SA; Akopov SB; Chernov IP; Thomsen PD; Joergensen C; Collins AR; Frengen E; Nikolaev LG
Genomics; 2007 Mar; 89(3):354-61. PubMed ID: 17188460
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic changes in cancer as potential targets for prophylaxis and maintenance therapy.
Grønbaek K; Treppendahl M; Asmar F; Guldberg P
Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):389-96. PubMed ID: 18947362
[TBL] [Abstract][Full Text] [Related]
11. Nuclear matrices and matrix attachment regions from Green alga: Dunaliella salina.
Wang TY; Hou WH; Chai YR; Ji X; Wang JM; Xue LX
Yi Chuan Xue Bao; 2005 Dec; 32(12):1312-8. PubMed ID: 16459661
[TBL] [Abstract][Full Text] [Related]
12. American Association for Cancer Research--100th Annual Meeting. New therapeutic developments: part 2. 18-22 April 2009, Denver, CO, USA.
Gale S; McGee V; Lee W
IDrugs; 2009 Jun; 12(6):335-8. PubMed ID: 19517309
[No Abstract] [Full Text] [Related]
13. American Association for Cancer Research--100th Annual Meeting. New therapeutic developments: part 1. 18-22 April 2009, Denver, CO, USA.
Gale S; McGee V; Lee W
IDrugs; 2009 Jun; 12(6):331-4. PubMed ID: 19517308
[No Abstract] [Full Text] [Related]
14. Molecular underpinnings of the targeted therapy for cancer.
Wcisło G
Acta Pol Pharm; 2008; 65(6):633-40. PubMed ID: 19172844
[TBL] [Abstract][Full Text] [Related]
15. Targeting transcription factors for cancer therapy.
Frank DA
IDrugs; 2009 Jan; 12(1):29-33. PubMed ID: 19127502
[TBL] [Abstract][Full Text] [Related]
16. Cancer treatment of the future: inhibitors of histone methyltransferases.
Spannhoff A; Sippl W; Jung M
Int J Biochem Cell Biol; 2009 Jan; 41(1):4-11. PubMed ID: 18773966
[TBL] [Abstract][Full Text] [Related]
17. Predictive biomarkers in the development of oncology drugs: a therapeutic industry perspective.
Fine BM; Amler L
Clin Pharmacol Ther; 2009 May; 85(5):535-8. PubMed ID: 19295504
[No Abstract] [Full Text] [Related]
18. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
Juillerat-Jeanneret L
Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic prospects for epigenetic modulation.
Heightman TD
Expert Opin Ther Targets; 2011 Jun; 15(6):729-40. PubMed ID: 21366500
[TBL] [Abstract][Full Text] [Related]
20. Determination of the in vivo distribution of nuclear matrix attachment regions using a polymerase chain reaction-based assay in Arabidopsis thaliana.
Tachiki K; Kodama Y; Nakayama H; Shinmyo A
J Biosci Bioeng; 2009 Jul; 108(1):11-9. PubMed ID: 19577185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
